Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 15 studies | 42% ± 18% | |
pericyte | 13 studies | 35% ± 22% | |
oligodendrocyte | 9 studies | 57% ± 28% | |
adipocyte | 8 studies | 51% ± 16% | |
mast cell | 8 studies | 37% ± 14% | |
fibroblast | 7 studies | 46% ± 19% | |
smooth muscle cell | 7 studies | 32% ± 12% | |
glutamatergic neuron | 6 studies | 46% ± 25% | |
cardiac muscle cell | 5 studies | 41% ± 15% | |
GABAergic neuron | 5 studies | 41% ± 25% | |
endothelial cell of lymphatic vessel | 5 studies | 46% ± 21% | |
naive B cell | 4 studies | 26% ± 4% | |
vein endothelial cell | 4 studies | 47% ± 25% | |
endothelial cell of vascular tree | 4 studies | 49% ± 20% | |
B cell | 4 studies | 19% ± 1% | |
memory B cell | 3 studies | 23% ± 2% | |
interneuron | 3 studies | 58% ± 22% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lymph node | 0% | 0 | 0 / 0 | 100% | 38.77 | 29 / 29 |
thymus | 0% | 0 | 0 / 0 | 97% | 21.16 | 588 / 605 |
kidney | 0% | 0 | 0 / 0 | 96% | 29.69 | 862 / 901 |
breast | 0% | 0 | 0 / 0 | 95% | 15.56 | 1064 / 1118 |
stomach | 0% | 0 | 0 / 0 | 94% | 13.81 | 270 / 286 |
pancreas | 0% | 0 | 0 / 0 | 94% | 16.70 | 168 / 178 |
eye | 0% | 0 | 0 / 0 | 94% | 10.75 | 75 / 80 |
skin | 0% | 0 | 0 / 0 | 92% | 18.72 | 435 / 472 |
lung | 0% | 0 | 0 / 0 | 92% | 14.30 | 1057 / 1155 |
esophagus | 0% | 0 | 0 / 0 | 88% | 13.58 | 161 / 183 |
prostate | 0% | 0 | 0 / 0 | 86% | 9.80 | 430 / 502 |
adrenal gland | 0% | 0 | 0 / 0 | 85% | 10.11 | 196 / 230 |
intestine | 0% | 0 | 0 / 0 | 85% | 10.83 | 448 / 527 |
brain | 0% | 0 | 0 / 0 | 85% | 9.11 | 598 / 705 |
liver | 0% | 0 | 0 / 0 | 82% | 8.31 | 333 / 406 |
ovary | 0% | 0 | 0 / 0 | 81% | 7.82 | 347 / 430 |
tonsil | 0% | 0 | 0 / 0 | 71% | 6.54 | 32 / 45 |
bladder | 0% | 0 | 0 / 0 | 67% | 8.80 | 340 / 504 |
uterus | 0% | 0 | 0 / 0 | 65% | 9.39 | 298 / 459 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
adipose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
muscle | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0008360 | Biological process | regulation of cell shape |
GO_0098552 | Cellular component | side of membrane |
GO_0016324 | Cellular component | apical plasma membrane |
GO_0005515 | Molecular function | protein binding |
Gene name | PALM2AKAP2 |
Protein name | PALM2 and AKAP2 fusion PALM2-AKAP2 fusion protein (A-kinase anchor protein 2) (AKAP-2) (AKAP-KL) (Paralemmin A kinase anchor protein) (Paralemmin-2) (Protein kinase A-anchoring protein 2) (PRKA2) |
Synonyms | KIAA0920 PAKAP PALM2 |
Description | FUNCTION: Binds to regulatory subunit (RII) of protein kinase A. May be involved in establishing polarity in signaling systems or in integrating PKA-RII isoforms with downstream effectors to capture, amplify and focus diffuse, trans-cellular signals carried by cAMP. Binds to and modulates the structure of the actin cytoskeleton. . |
Accessions | ENST00000259318.7 [Q9Y2D5-3] ENST00000374525.5 [Q9Y2D5-5] ENST00000480388.1 ENST00000497711.1 ENST00000674068.1 ENST00000495980.1 ENST00000302798.7 [Q9Y2D5-6] ENST00000413420.5 ENST00000434623.6 [Q9Y2D5-7] A0A669KBK1 ENST00000374530.8 [Q9Y2D5-4] C9JA33 ENST00000374531.6 [Q9Y2D5-9] C9JZH4 F8WF36 ENST00000314527.9 [Q9Y2D5-8] B1ALY0 ENST00000483909.5 Q9Y2D5 C9JVY5 |